Teva Pharmaceutical Industries (NYSE:TEVA) Updates FY 2019 Pre-Market Earnings Guidance
Teva Pharmaceutical Industries (NYSE:TEVA) updated its FY 2019Pre-Market earnings guidance on Monday. The company provided EPS guidance of $2.30-2.50 for the period, compared to the Thomson Reuters consensus EPS estimate...









